BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8940474)

  • 1. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy.
    Ruhnke M; Schmidt-Westhausen A; Engelmann E; Trautmann M
    J Clin Microbiol; 1996 Dec; 34(12):3208-11. PubMed ID: 8940474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.
    Espinel-Ingroff A; Rodríguez-Tudela JL; Martínez-Suárez JV
    J Clin Microbiol; 1995 Dec; 33(12):3154-8. PubMed ID: 8586692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].
    Ruhnke M; Schmidt-Westhausen A; Trautmann M
    Mycoses; 1996; 39 Suppl 2():47-50. PubMed ID: 9198745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
    Martín-Mazuelos E; Gutiérrez MJ; Aller AI; Bernal S; Martínez MA; Montero O; Quindós G
    J Antimicrob Chemother; 1999 Apr; 43(4):477-81. PubMed ID: 10350375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
    Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
    Dannaoui E; Colin S; Pichot J; Piens MA
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):228-32. PubMed ID: 9131326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
    J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
    Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
    J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
    Ruhnke M; Schmidt-Westhausen A; Trautmann M
    Antimicrob Agents Chemother; 1997 Mar; 41(3):575-7. PubMed ID: 9055995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
    Tortorano AM; Viviani MA; Barchiesi F; Arzeni D; Rigoni AL; Cogliati M; Compagnucci P; Scalise G
    J Clin Microbiol; 1998 Jun; 36(6):1578-83. PubMed ID: 9620380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients.
    Silva Mdo R; Costa MR; Miranda AT; Fernandes Ode F; Costa CR; Paula CR
    Rev Inst Med Trop Sao Paulo; 2002; 44(3):121-5. PubMed ID: 12163903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.